Back to company

Pharmyn ApS: Financial statements 2018

CVR: 37133892

Pharmyn ApS (CVR 37133892) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 288 and a net result of DKK 88 compared with DKK -3,947 the year before. Equity amounted to DKK 42,379. The solvency ratio was 84.4%.

Gross Profit
288 kr.
Profit/Loss
88 kr.
Equity
42,379 kr.
Total Assets
50,201 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-2888842 t.0
2017--4 t.-4 t.42 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Pharmyn ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

Pharmyn ApS: The 2017 annual report is outApr 30, 2018

Pharmyn ApS has published its annual report for 2017. Gross profit came to DKK -3,947, and the net result was DKK -3,947.

About Pharmyn ApS

Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity amounted to DKK 18,662.